Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma von Rajkumar, S Vincent, Hayman, Suzanne, Gertz, Morie A, Dispenzieri, Angela, Lacy, Martha Q, Greipp, Philip R, Geyer, Susan, Iturria, Nancy, Fonseca, Rafael, Lust, John A, Kyle, Robert A, Witzig, Thomas E

Volltext

Clinical Course of Patients With Relapsed Multiple Myeloma von Kumar, Shaji K., Therneau, Terry M., Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela, Rajkumar, S. Vincent, Fonseca, Rafael, Witzig, Thomas E., Lust, John A., Larson, Dirk R., Kyle, Robert A., Greipp, Philip R.

Volltext

Thalidomide as initial therapy for early-stage myeloma von RAJKUMAR, S. V, GERTZ, M. A, GREIPP, P. R, WITZIG, T. E, LACY, M. Q, DISPENZIERI, A, FONSECA, R, GEYER, S. M, ITURRIA, N, KUMAR, S, LUST, J. A, KYLE, R. A

Volltext

Thalidomid: Current role in the treatment of non-plasma cell malignancies von KUMAR, Shaji, WITZIG, Thomas E, RAJKUMAR, S. Vincent

Volltext

Rituximab for IgG4-related disease: a prospective, open-label trial von Carruthers, Mollie N, Topazian, Mark D, Khosroshahi, Arezou, Witzig, Thomas E, Wallace, Zachary S, Hart, Philip A, Deshpande, Vikram, Smyrk, Thomas C, Chari, Suresh, Stone, John H

Volltext

Thalidomide in the Treatment of Relapsed Multiple Myeloma von Rajkumar, S. Vincent, Fonseca, Rafael, Dispenzieri, Angela, Lacy, Martha Q., Lust, John A., Witzig, Thomas E., Kyle, Robert A., Gertz, Morie A., Greipp, Philip R.

Volltext

Thalidomide for previously untreated indolent or smoldering multiple myeloma von RAJKUMAR, S. V, DISPENZIERI, A, FONSECA, R, LACY, M. Q, GEYER, S, LUST, J. A, KYLE, R. A, GREIPP, P. R, GERTZ, M. A, WITZIG, T. E

Volltext

Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma von KUMAR, S, WITZIG, T. E, RAJKUMAR, S. V, DISPENZIERI, A, LACY, M. Q, WELLIK, L. E, FONSECA, R, LUST, J. A, GERTZ, M. A, KYLE, R. A, GREIPP, P. R

Volltext

High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy von KUMAR, S, LACY, M. Q, KYLE, R. A, LITZOW, M. R, GERTZ, M. A, DISPENZIERI, A, RAJKUMAR, S. V, FONSECA, R, GEYER, S, ALLMER, C, WITZIG, T. E, LUST, J. A, GREIPP, P. R

Volltext

Response Rate, Durability of Response, and Survival After Thalidomide Therapy for Relapsed Multiple Myeloma von Kumar, Shaji, Gertz, Morie A., Dispenzieri, Angela, Lacy, Martha Q., Geyer, Susan M., Iturria, Nancy L., Fonseca, Rafael, Hayman, Suzanne R., Lust, John A., Kyle, Robert A., Greipp, Philip R., Witzig, Thomas E., Rajkumar, S. Vincent

Volltext

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma von RAJKUMAR, S. V, FONSECA, R, WITZIG, T. E, GERTZ, M. A, GREIPP, P. R

Volltext

Targeting Apoptosis Pathways in Cancer Therapy von Ghobrial, Irene M, Witzig, Thomas E, Adjei, Alex A

Volltext

Regulation of STAT3 by histone deacetylase-3 in diffuse large B-cell lymphoma: implications for therapy von Gupta, M, Han, J J, Stenson, M, Wellik, L, Witzig, T E

Volltext

Life-Threatening Toxic Epidermal Necrolysis with Thalidomide Therapy for Myeloma von Rajkumar, S. Vincent, Gertz, Morie A, Witzig, Thomas E

Volltext

Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy von KUMAR, S, GERTZ, M. A, RAJKUMAR, S. V, DISPENZIERI, A, LACY, M. Q, WELLIK, L. A, FONSECA, R, LUST, J. A, WITZIG, T. E, KYLE, R. A, GREIPP, P. R

Volltext

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis von Dispenzieri, Angela, Lacy, Martha Q., Rajkumar, S. Vincent, Geyer, Susan M., Witzig, Thomas E., Fonseca, Rafael, Lust, John A., Greipp, Philip R., Kyle, Robert A., Gertz, Morie A.

Volltext

Association of aspirin and other non‐steroidal anti‐inflammatory drug use with incidence of non‐hodgkin lymphoma von Cerhan, James R., Anderson, Kristin E., Janney, Carol A., Vachon, Celine M., Witzig, Thomas E., Habermann, Thomas M.

Volltext

Thalidomide as an anti‐cancer agent von Kumar, S., Witzig, T. E., Rajkumar, S. V.

Volltext

Current Treatment Approaches for Mantle-Cell Lymphoma von Witzig, Thomas E

Volltext

International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease von Khosroshahi, A., Wallace, Z. S., Crowe, J. L., Akamizu, T., Azumi, A., Carruthers, M. N., Chari, S. T., Della‐Torre, E., Frulloni, L., Goto, H., Hart, P. A., Kamisawa, T., Kawa, S., Kawano, M., Kim, M. H., Kodama, Y., Kubota, K., Lerch, M. M., Löhr, M., Masaki, Y., Matsui, S., Mimori, T., Nakamura, S., Nakazawa, T., Ohara, H., Okazaki, K., Ryu, J.H., Saeki, T., Schleinitz, N., Shimatsu, A., Shimosegawa, T., Takahashi, H., Takahira, M., Tanaka, A., Topazian, M., Umehara, H., Webster, G. J., Witzig, T. E., Yamamoto, M., Zhang, W., Chiba, T., Stone, J. H.

Volltext